Preservation of myocardial ultrastructural integrity following ischemic arrest. Clinical use of nifedipine cardioplegia. Preliminary report
Donegani, E.; De Paulis, R.; Di Summa, M.; Poletti, G.A.; Morea, M.; Matani, A.
Rivista Europea Per le Scienze Mediche e Farmacologiche 9(4): 363-367
1987
ISSN/ISBN: 0392-291X PMID: 3508613 Document Number: 300508
Document emailed within 1 workday
Related Documents
Lucas, S.K.; Magee, P.G.; Flaherty, J.T.; Gott, V.L.; Gardner, T.J. 1979: Additive myocardial protection during ischemic arrest with propranolol and potassium cardioplegia Surgical Forum 30: 257-260Okuda, M.; Lefer, A.M. 1976: Preservation of myocardial membrane integrity in the early phase of acute myocardial ischemia Recent Advances in Studies on Cardiac Structure and Metabolism 12: 507-511
Hearse, D.J.; Stewart, D.A.; Braimbridge, M.V. 1980: The additive protective effects of hypothermia and chemical cardioplegia during ischemic cardiac arrest in the rat Journal of Thoracic and Cardiovascular Surgery 79(1): 39-43
Sunamori, M.; Harrison, C.E. 1979: Myocardial respiration and edema following hypothermic cardioplegia and anoxic arrest Journal of Thoracic and Cardiovascular Surgery 78(2): 208-216
Balderman, S.C.; Chan, A.K.; Gage, A.A. 1984: Verapamil cardioplegia: improved myocardial preservation during global ischemia Journal of Thoracic and Cardiovascular Surgery 88(1): 57-66
Orita, H. 1985: Intramyocardial pH and PCO2 monitoring as an index of myocardial preservation during anoxic arrest and reperfusion Nihon Kyobu Geka Gakkai 33(7): 1028-1042
Menasché, P.; Kucharski, K.; Mundler, O.; Veyssié, L.; Subayi, J.B.; Le Pimpec, F.; Fauchet, M.; Piwnica, A. 1989: Adequate preservation of right ventricular function after coronary sinus cardioplegia. A clinical study Circulation 80(5 Part 2): Iii19-Iii24
Gharagozloo, F.; Bulkley, B.H.; Hutchins, G.M.; Bixler, T.J.; Schaff, H.V.; Flaherty, J.T.; Gardner, T.J. 1979: Potassium-induced cardioplegia during normothermic cardiac arrest. Morphologic study of the effect of varying concentrations of potassium on myocardial anoxic injury Journal of Thoracic and Cardiovascular Surgery 77(4): 602-607
Pearl, J.M.; Laks, H.; Drinkwater, D.C.; Meneshian, A.; Sun, B.; Gates, R.N.; Chang, P. 1993: Normocalcemic blood or crystalloid cardioplegia provides better neonatal myocardial protection than does low-calcium cardioplegia Journal of Thoracic and Cardiovascular Surgery 105(2): 201-206
Kacila, M.; Granov, N.; Straus, S.; Omerbasić, E.; Saefer, K.; Donlić, E. 2006: Antegrade warm blood cardioplegia compared to crystalloid cardioplegia in myocardial protection Medicinski Arhiv 60(5): 294-295
Pise, M.; Korukonda, K.Prasad.; Walwaikar, P.P. 2009: Compiled report on clinical efficacy and safety of nifedipine retard 10/20/nifedipine CD 30, as a first-line/add-on therapy in patients of hypertension: ENHANS trial Journal of the Indian Medical Association 107(2): 114-116
Lurie, K.G.; Billingham, M.E.; Masek, M.A.; Ginsburg, R.; Bristow, M.R.; Harrison, D.; Reitz, B.A. 1982: Ultrastructural and functional studies on prolonged myocardial preservation in an experimental heart transplant model Journal of Thoracic and Cardiovascular Surgery 84(1): 122-129
Hearse, D.J.; Stewart, D.A.; Braimbridge, M.V. 1978: Myocardial protection during ischemic cardiac arrest. the importance of magnesium in cardioplegic infusates Journal of Thoracic and Cardiovascular Surgery 75(6): 877-885
Rosenkranz, E.R.; Okamoto, F.; Buckberg, G.D.; Robertson, J.M.; Vinten-Johansen, J.; Bugyi, H.I. 1986: Safety of prolonged aortic clamping with blood cardioplegia. III. Aspartate enrichment of glutamate-blood cardioplegia in energy-depleted hearts after ischemic and reperfusion injury Journal of Thoracic and Cardiovascular Surgery 91(3): 428-435
Hashimoto, K.; Pearson, P.J.; Schaff, H.V.; Cartier, R. 1991: Endothelial cell dysfunction after ischemic arrest and reperfusion: a possible mechanism of myocardial injury during reflow Journal of Thoracic and Cardiovascular Surgery 102(5): 688-694
Hearse, D.J.; Stewart, D.A.; Braimbridge, M.V. 1978: Myocardial protection during ischemic cardiac arrest. Possible deleterious effects of glucose and mannitol in coronary infusates Journal of Thoracic and Cardiovascular Surgery 76(1): 16-23
Jiang, H.; Rao, M.R. 1993: Protective effects of m-nifedipine and nifedipine in isolated ischemic-reperfused rat hearts Yao Xue Xue Bao 28(1): 1-5
Chen, N.H.; Rao, M.R. 1989: Protective effects of m-nifedipine and nifedipine on ischemic-reperfused injury in working guinea pig hearts Zhongguo Yao Li Xue Bao 10(2): 156-161
Kraska, T.; Zochowski, R.J.; Korewicki, J.; Opolski, G.; Pieniak, M. 1978: Preliminary clinical experiences with continuous intravenous nitroglycerin infusion in the treatment of acute myocardial infarct. Preliminary clinical communication Kardiologia Polska 21(4): 301-308
Ishizaka, M. 1977: Myocardial protection by retrograde cardiac perfusion with cold Medified Krebs solution through coronary sinus during complete ischemic arrest for 120 min Nihon Kyobu Geka Gakkai 25(12): 1592-1601